Your browser doesn't support javascript.
loading
Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer.
Hotta, K; Hida, T; Nokihara, H; Morise, M; Kim, Y H; Azuma, K; Seto, T; Takiguchi, Y; Nishio, M; Yoshioka, H; Kumagai, T; Watanabe, S; Goto, K; Satouchi, M; Kozuki, T; Shukuya, T; Nakagawa, K; Mitsudomi, T; Yamamoto, N; Asakawa, T; Yoshimoto, T; Takata, S; Tamura, T.
Afiliação
  • Hotta K; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama. Electronic address: khotta@okayama-u.ac.jp.
  • Hida T; Department of Thoracic Oncology, Aichi Cancer Center, Nagoya, Aichi.
  • Nokihara H; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo.
  • Morise M; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya.
  • Kim YH; Department of Respiratory Medicine, Kyoto University, Kyoto.
  • Azuma K; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Fukuoka.
  • Seto T; Department of Thoracic Oncology, National Hospital Organization Kyusyu Cancer Center, Fukuoka.
  • Takiguchi Y; Department of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba.
  • Nishio M; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo.
  • Yoshioka H; Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata, Osaka.
  • Kumagai T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka.
  • Watanabe S; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata.
  • Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba.
  • Satouchi M; Department of Thoracic Oncology, Hyogo Cancer Center, Akashi, Hyogo.
  • Kozuki T; Department of Thoracic Oncology and Medicine, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime.
  • Shukuya T; Department of Respiratory Medicine, Juntendo University, Tokyo.
  • Nakagawa K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka.
  • Mitsudomi T; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka.
  • Yamamoto N; Third Department of Internal Medicine, Wakayama Medical University, Wakayama.
  • Asakawa T; Biometrics Department, Chugai Pharmaceuticals Co. Ltd, Tokyo.
  • Yoshimoto T; Biometrics Department, Chugai Pharmaceuticals Co. Ltd, Tokyo.
  • Takata S; Oncology Clinical Development Department, Chugai Pharmaceuticals Co. Ltd, Tokyo.
  • Tamura T; Thoracic Center, St. Luke's International Hospital, Tokyo, Japan.
ESMO Open ; 7(4): 100527, 2022 08.
Article em En | MEDLINE | ID: mdl-35843080
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: ESMO Open Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: ESMO Open Ano de publicação: 2022 Tipo de documento: Article